Drexel University Center for Drug Discovery

Therapeutic Approaches: Small Molecules, Biomarkers

Therapeutic Areas of Expertise: Neurological Disorders, Oncology, Pain

Center/Program Highlights: The Drexel University Center for Drug Discovery specializes in the identification of novel targets for cancer, neurodegenerative diseases and pain, coupled to a robust medicinal chemistry effort that is integrated into a comprehensive approach for early stage drug discovery, in vitro and in vivo and validation and early stage drug development.

Sources of Funding: Federal/State, University, Venture Capital, private investors


Institutional Affiliation(s): Drexel University College of Medicine

245 N. 15th Street
Department of Pharmacology and Physiology
Pennsylvania, 19102
United States

Center/Program Start Date: 2010

Number of Employees: 15